nos.nl
ADHD Medication Use Quadruples in Netherlands
The number of people using ADHD medication in the Netherlands quadrupled between 2006 and 2023, reaching almost 300,000, driven by increased diagnoses, particularly among women, while concerns remain about off-label use among students.
- How do differences in ADHD presentation between genders affect diagnosis and treatment rates, and what are the consequences?
- Increased awareness and understanding of ADHD in women, often characterized by mental rather than physical hyperactivity, likely contribute to the rise in female prescriptions. Improved diagnosis and treatment access explain the overall increase in medication use across all age groups.
- What is the extent of the increase in ADHD medication use in the Netherlands over the past 17 years, and what are the immediate implications of this trend?
- The number of people using ADHD medication in the Netherlands quadrupled in 17 years, reaching almost 300,000 in 2023 from 78,000 in 2006. This increase is particularly driven by a rise in female users, narrowing the gender gap in medication use. While boys still receive more prescriptions under 20, the difference diminishes afterward.
- What are the potential long-term societal impacts of the rising ADHD medication use, considering its implications for healthcare access, workplace dynamics, and societal understanding of ADHD?
- The rising trend in ADHD medication use, especially among women and older adults, suggests increased awareness and diagnosis. Future research should investigate the long-term effects of this increase and potential societal implications, including increased access to healthcare and changes in societal understanding of ADHD.
Cognitive Concepts
Framing Bias
The article frames the increase in ADHD medication use as a largely positive development, highlighting the improved quality of life for individuals like Hanneke Mijnster. While acknowledging potential underdiagnosis in the past, it doesn't significantly explore potential negative consequences of increased medication use or the possibility of overdiagnosis.
Language Bias
The language used is generally neutral, however, phrases such as "dromeriger" (dreamier) when describing women with ADHD could be interpreted as subtly biased, implying a lack of focus that might not be universally true for all women with ADHD. A more neutral description of their symptoms would improve objectivity.
Bias by Omission
The article focuses heavily on the increase in ADHD medication use, but omits data on the total number of diagnoses. It also lacks information on the prevalence of medication use without prescriptions, mentioning only a statistic from the Trimbos Institute regarding students. This omission limits the reader's ability to form a complete understanding of the situation.
False Dichotomy
The article doesn't present a false dichotomy, but it could benefit from acknowledging the complexities surrounding ADHD diagnosis and treatment. While it mentions the increased awareness and diagnosis in women, it doesn't delve into potential criticisms of overdiagnosis or the limitations of medication as the sole treatment.
Gender Bias
The article highlights the underdiagnosis of ADHD in women in the past and the subsequent increase in medication use among them. It uses a female case study to illustrate the benefits of medication. While this addresses a gender imbalance, it could benefit from further discussion of how gender may impact diagnosis criteria or treatment approaches.
Sustainable Development Goals
The increase in ADHD medication use reflects improved diagnosis and treatment, contributing to better mental health and well-being. The article highlights improved recognition of ADHD symptoms in women and increased access to medication, leading to better management of the condition.